The Open Drug Safety Journal




(Discontinued)

ISSN: 1876-8180 ― Volume 4, 2013

Voriconazole Induced Severe Liver Toxicity Post Keratitis



Fahad I Al-Saikhan*
College of Pharmacy, Salman Bin Abdulaziz University, Al-Kharj, KSA

Abstract

The case involved a 72-year old Saudi female patient who was treated for fungal keratitis. Aspergillus species was confirmed. The patient showed mild liver impairment upon admission. Antimicrobial eye drop solutions which comprise the medicines for the treatment regimen included antibiotics (gentamicin, cefazoline, ceftazidine, and moxifloxacin) and antifungal (amphotericin B and, voriconazole) that were started on day one, as well as, voriconazole systemic. On day 9 of the hospitalization, the liver function tests (LFTs) revealed significantly higher values compared to day zero. All medicines were continued at their usual doses and no adverse drug reaction was reported. On Day 13, the patient experienced abdominal pain, hallucination, nausea, tachycardia, and vomiting, in addition to elevated LFTs. At this time, oral voriconazole was discontinued. Patient was discharged with no further reports. An analysis of adverse drug event (ADE) report was performed and results showed that systemic voriconazole is the possible cause of the significant increase in LFTs and the manifested symptoms of liver toxicity.

Keywords:: Voriconazole, keratitis, Aspergillus, liver toxicity.


Article Information


Identifiers and Pagination:

Year: 2013
Volume: 4
First Page: 1
Last Page: 2
Publisher Id: TODSJ-4-1
DOI: 10.2174/1876818001304010001

Article History:

Received Date: 21/8/2013
Revision Received Date: 28/9/2013
Acceptance Date: 30/9/2013
Electronic publication date: 18/10/2013
Collection year: 2013

© Fahad I. Al-Saikhan; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.


* Address correspondence to this author at the College of Pharmacy, Salman Bin Abdulaziz University, Al-Kharj, KSA; Tel: +966 115886074; Fax: +966 115886001; Email: fsaikhan@hotmail.com





INTRODUCTION

72-year old Saudi female in this case was under treatment for microbial keratitis. Initial tests upon admission showed mild impairment of the liver. LFTs evaluation revealed mild increase as follow: Gamma-glutamyltransferase (GGT) 147 Unit/Liter (U/L), Alanine transaminase (ALT) 69 U/L, and Alkaline phosphatase (ALP) 147 U/L. Aspergillus species was confirmed. However, no susceptibility testing was conducted for voriconazole (an antifungal) before it was administered in the hospital.

The treatment regimen included: antimicrobial eye drops using the antibiotics gentamicin, cefazoline, ceftazidine, and moxifloxacin which all initiated on day zero then discontinued on day two except for the later. Antifungals amphotericin B eye drops, voriconazole eye drops, as well as oral voriconazole 200 milligram (mg) were commenced on day one. However, no sensitivity testing was conducted. On day 9, the patient’s laboratory results showed a significant increase in the LFTs as follows: GGT 253 U/L, ALT 139 U/L, and ALP 197 U/L. No ADE report was submitted and none of the medicines included in the treatment regimen (voriconazole topical and system, amphotericin B topical, and moxifloxacin topical) were discontinued until Day 13. On this date, the patient experienced abdominal pain, hallucination, nausea, tachycardia, and vomiting, in addition to substantial elevation in LFTs (GGT 534 U/L, ALT 148 U/L, and ALP 278 U/L). This paper discusses the possible causes of the considerable increase in specific liver enzymes and other symptoms experienced by the patient. It is also of noteworthy to trace any lapses which may have transpired, and their implications in our patient.

DISCUSSION

Confirmation of the initial diagnosis for the presenting symptoms of the case is an important process in the treatment to ensure that the appropriate medicines are prescribed.

There are two primary causes of raised plasma GGT and ALP: either liver disease or induction of microsomal enzymes by alcohol or most likely by drugs [1]. A review of drug adverse reactions may provide a more meaningful analysis of the case grounded on research evidence that:

This is a Saudi female that is not consuming alcohol therefore less likely to be the cause of raised LFTs. In addition, women typically consume less alcohol than men when they drink, drink alcohol less frequently, and are less likely to develop alcohol related problems than men [2].

It is reported that systemic administration of amphotericin B and gentamicin could be a factor in elevation of LFTs [3]. However, in this case both were administered topically. And gentamicin was administered only from day zero to day two.

There were concerns pertaining to liver toxicity related to the administration of systemic voriconazole. However, a series of tests has already been performed in response to concerns articulated by some sectors of the medical community. Results of these tests, particularly, three randomized trials of voriconazole revealed that the frequency of abnormalities from LFTs after administration of systemic voriconazole was not significantly different from those of systemic amphotericin [4].

Additionally, a review of unpublished studies which employed regression analysis on a total of 3000 samples from 1000 patients in 10 trials accounted for a weak and inconsistent association of abnormal results of liver function tests with plasma concentrations of voriconazole after systemic administration. A number of studies provide evidence of major adverse effects from systemic voriconazole including elevated hepatic enzymes among ≥ 20% of patients [5, 6]. It was, however, recommended that individual dosage among patients be modified based on voriconazole plasma concentration levels [4].

In our case, voriconazole 200 mg orally every 12 hours and voriconazole 1% drops on the left eye every hour were prescribed. With reference to the standard guidelines on administering voriconazole, [7] it was observed that the loading dose 200 mg orally for two doses was given to the patient, which presumably weighs less than 40 kilogram (kg). But continued on maintenance dose of 200 mg every twelve hours for 13 days. The dosage administered to our patient who showed mild impairment of the liver function was not modified or customized based on the patient’s condition upon admission. Moreover, based on the aforementioned guidelines prepared from the Infectious Diseases Society of America, in patients with mild to moderate hepatic impairment (Child-Pugh Class A and B), 100 mg of voriconazole may be administered every 12 hours for patients who weigh > 40 kg and 50 mg every 12 hours for patients who weigh <40 kg. [7].

There is, therefore, reason to believe that the dosage given to the patient did not conform with the guidelines of the healthcare facility where the patient is being treated. This non-conformance to clinical protocol could most probably be the reason for the spike in patient’s LFTs (GGT and ALP) above normal levels. In spite of the high GGT and ALP reported from the patient’s laboratory result, the patient continued receiving the same dose of systemic voriconazole until Day 13 of confinement. Besides the internal clinical guidelines from the healthcare facility on the administration of systemic voriconazole, there is research evidence that adjustments are necessary for systemic voriconazole dosage among patients known to have mild or moderate hepatic impairment [8, 9].

As indicated in our case, patient suffered from the following symptoms on Day 13: abdominal pain, hallucination, nausea, tachycardia, and vomiting, in addition to elevated LFTs. Nausea and vomiting were reported among the adverse effects of voriconazole [4]. Abdominal pain, hallucination, and tachycardia were also known adverse effects of voriconazole [10]. Thus, patient symptoms were manifested in the central nervous system, together with cardiovascular, gastro-intestinal problems, and significantly increased GGT and ALP.

There was apparent lapse in the management of patient safety when the bedside nurse did not call the attention of concerned authorities regarding the adverse effect of the treatment regimen on the patient. The ophthalmologist should have also seen the patient chart with the result of the LFT and the elevated GGT and ALP. Generally accepted protocol in this regard is for the attending nurse or the bedside nurse to fill in an ADE report. Which was a routine procedure at this facility to report any ADE due to use of any medication? The reported side effect for our case was only submitted on day 13.

CONCLUSION

In retrospect, health care practitioners should be aware about the seriousness of liver injury from systemic voriconazole administration, which may include mild or transient elevation of LFTs or hepatic impairment at the worst. There have also been reports of voriconazole-induced acute liver failure [11]. Such complications might require liver transplant and may even cause death. Caution should always be taken when voriconazole is administered to patients. Dose adjustment is generally recommended for patients with hepatic impairment. The health care team should always be on the lookout for manifestations of liver toxicity.

CONFLICT OF INTEREST

The author(s) confirm that this article content has no conflicts of interest.

ACKNOWLEDGEMENT

Declared none.

REFERENCES

Track Your Manuscript:


Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents




Webmaster Contact: info@benthamopen.net
Copyright © 2021 Bentham Open